Corbus Pharmaceuticals Holdings, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -0.2002 | -100% |
| P/S |
|
0 | 33.77 | -100% |
|
|
| P/BV |
|
-3.45 | 4.83 | -171.4% |
|
|
| P/FCF |
|
-0.795 | 61 | -101.3% |
|
|
| Ev/Ebitda |
|
-0.6924 | -22.17 | -96.88% |
|
|
| Ev/S |
|
0 | 22.57 | -100% |
|
|
| Ev/FCF |
|
-0.8523 | 68.76 | -101.24% |
|
|
| E/P |
|
-1.55 | 0.0178 | -8820.76% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.97 | -100% | -2434.6 | -100% |
| ROE |
|
645.98 | 9.61 | 6620.88% |
|
|
| ROA |
|
-157.76 | 0.3443 | -45926.71% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
652.85 | 15.45 | 4125.68% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.47 | -3.68 | -87.22% | -0.4849 | -3.08% |
| Nеt Debt/Ebitda |
|
-0.1568 | -3.44 | -95.44% |
|
|
| Debt/Ratio |
|
0.7387 | 0.1986 | 271.97% |
|
|
| Debt/Equity |
|
0.3469 | 1.66 | -79.13% |
|
|
| Debt/Net Income |
|
-0.4682 | 10.32 | -104.54% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-63.87 | -57.64 | 10.81% | ||
| Growth impulse Ebitda in 5 years |
|
-42.25 | -90.94 | -53.54% | ||
| Growth impulse Net Income in 5 years |
|
-31.1 | -97.8 | -68.2% | ||
| Growth impulse FCF in 5 years |
|
-25.51 | -108.72 | -76.54% | ||
| Growth impulse EPS in 5 years |
|
-66.09 | -142.05 | -53.47% |
IP Score
3.13/10
